What Envue Technologies does

Envue Technologies is a Swedish biotech instrumentation company, founded as a spinout from the Langhammer group at Chalmers University of Technology and headquartered at Stena Center, Läraregatan 3, Gothenburg. The company develops and commercializes a label-free optical microscopy platform called Nanofluidic Scattering Microscopy (NSM), which combines cleanroom-fabricated nanofluidic chips, a custom-built dark-field optical microscope, and a proprietary data analysis pipeline (combining machine learning with conventional algorithms) to image and characterize freely moving single biomolecules — down to tens of kDa — in real time without fluorescent labels. The NSM method and its ability to simultaneously determine mass and size of individual nanoscale objects were published in Nature Methods in May 2022, anchoring Envue's scientific credibility.

Envue monetizes the NSM platform through two product lines — the modular Custom Instrument (a research-grade microscope-plus-chips-plus-software system) and the EnvueR One all-in-one benchtop instrument — and complements hardware sales with a paid Sample Analysis Service, where customers submit sample details and receive a quoted timeframe and price. Distribution is direct (no resellers or marketplace listings) with CTAs for demo and sample analysis, and the company targets biopharma/drug-discovery research (nucleic acid and protein therapeutics, molecular interactions, oligomer QC) as well as academic and analytical QC labs. Capitalization was predominantly non-dilutive — Swedish and EU grants from Vinnova (~900,000 SEK), the ÅForsk Foundation (200,000 SEK scholarship to the CEO), and the EIC WomenTechEU programme (€75,000) — supplemented by a small Chalmers Ventures commitment. In November 2025, Envue was acquired by NanoTemper Technologies GmbH (Munich), with the NSM technology integrated into NanoTemper's biophysical analysis portfolio alongside the launch of the Dianthus α application for drug discovery.

Name

Envue Technologies

Legal name

Envue Technologies

Website

https://envue-technologies.com

Company type

Private

Founded year

2022

Operating status

Acquired

Headcount range

1–10 employees

Short description

Envue Technologies is a Swedish biotech instrumentation spinout from Chalmers University of Technology that develops Nanofluidic Scattering Microscopy (NSM), a label-free optical platform for real-time mass and size characterization of single biomolecules, sold to biopharma and academic research labs via the Custom Instrument, EnvueR One, and a paid Sample Analysis Service.

Ownership category

akta.pro rank

Product category

Biophysical Analysis Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)

Keywords

• Label-free optical microscopy
• Biomolecule characterization instruments
• Nanofluidic scattering microscopy
• Biophysical analysis tools
• Nanoparticle characterization systems

Headquarters

HQ city

Göteborg

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Instrument Sales: Sale of the Custom Instrument and EnvueR One scientific instruments — next-generation instruments for characterizing objects in the nanoworld. Capital equipment sales model targeting biopharma and academic research labs.
2. Sample Analysis Services: Paid sample analysis service — customers submit samples and Envue returns a suggested timeframe and a quote. Likely a land-and-expand motion converting service customers into instrument purchasers.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

Core offering

Envue Technologies develops, manufactures, and commercializes scientific instruments based on its proprietary Nanofluidic Scattering Microscopy (NSM) platform for the label-free characterization of biomolecules and nanoparticles. The company sells a modular Custom Instrument, an all-in-one EnvueR One benchtop instrument, and bundled nanofluidic chips with proprietary data analysis software, alongside fee-based sample analysis services for drug discovery and academic research customers.

Product overview

Envue Technologies offers a single unified scientific-instrument platform built around its proprietary Nanofluidic Scattering Microscopy (NSM) method, delivered through two hardware product lines — The Custom Instrument (a modular microscope-plus-chips-plus-software system for research users) and The EnvueR One (an all-in-one benchtop instrument for routine mass and size measurements). Both products share the same three core technology elements: a cleanroom-fabricated nanofluidic chip, a specially designed dark-field optical microscope, and proprietary data-analysis software that combines machine learning with conventional algorithms. In November 2025, Envue was acquired by NanoTemper Technologies GmbH, integrating NSM into a broader biopharma drug-discovery portfolio alongside the newly launched Dianthus α application. Envue also monetizes the underlying capability directly via a Sample Analysis Service for customers who do not yet own an instrument.

Differentiator

Problem solved

Functional benefit

Products and services

• The Custom Instrument

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature7 records

Partnerships

Three partnerships are on record, tiered flagship, minor and core.

• NanoTemper Technologies GmbHflagshipStrategic or Co-development Partner · 5 November 2025NanoTemper Technologies GmbH announced the acquisition of Swedish startup Envue Technologies and the launch of its Dianthus α application on 2025-11-05/06. The acquisition integrates Envue's Nanofluidic Scattering Microscopy (NSM) technology into NanoTemper's biophysical analysis portfolio for drug discovery.
• REACH Incubator Program (Silicon Valley)minorStrategic or Co-development Partner · 28 September 2022Envue selected to participate in REACH, a Silicon Valley-based incubator program designed to boost Nordic research-based tech projects and spin-outs with international ambitions. Program spans a year including a two-week trip to Silicon Valley in March 2023.
• Chalmers University of Technology — Langhammer GroupcoreStrategic or Co-development PartnerEnvue was started as a spinout company from the Langhammer group at Chalmers University of Technology. The NSM method was developed by combining expertise in nano fabrication, nano optics and biophysics at Chalmers.

Scale indicators6 records

Recent moves1 record

Expansion highlights5 records

Broad incumbents

• Agilent Technologies: Analytical instrument and biocolumns vendor (SEC, CE, mass spec) serving biopharma characterization workflows. Comparable because it competes for analytical budget around protein and nucleic acid characterization in discovery and QC.
• Cytiva (Danaher): Supplies bioprocess and analytical tools (ÄKTA, MicroCal ITC/DSF) used across biopharma discovery, developability, and QC. Comparable because it sells complementary label-free characterization workflows to the same biopharma buyer.
• Malvern Panalytical: Established label-free particle-sizing incumbent via Zetasizer (DLS) and NanoSight (NTA). Comparable because these are the primary alternative label-free techniques that NSM positions against for biomolecule and nanoparticle characterization.
• Wyatt Technology: Provides SEC-MALS, DLS (DynaPro), and field-flow fractionation for absolute molecular weight and size of biomolecules. Comparable because it competes for the same protein, nucleic acid, and aggregate characterization budgets in biopharma R&D and QC.
• Thermo Fisher Scientific: Largest life-sciences tools vendor with mass spectrometry, microcalorimetry, and chromatography for protein characterization. Comparable as the broadest incumbent that could compete with or absorb NSM-style capabilities over time.
• Bruker: Large analytical instrument vendor with mass spectrometry, AFM, and biophysical tools relevant to protein characterization. Comparable as a broad incumbent with the ability to bundle orthogonal label-free techniques alongside NSM-type offerings.

Emerging players

• Fluidic Analytics: Developer of microfluidic label-free tools (Fluidity One) for protein interaction and sizing measurements. Comparable as a smaller player using microfluidics to deliver label-free biomolecule characterization in similar customer segments.
• Unchained Labs: Sells benchtop biophysical tools for biologics developability (e.g., Uncle, Hunky, LUNATIC). Comparable because it targets the same biologics-formulation and developability workflows that NSM's mass/size and aggregation use cases address.

Direct peers

• Refeyn: Refeyn commercializes mass photometry, the most established label-free single-molecule mass measurement technique. It is the closest direct competitor to Envue's NSM, serving the same biopharma discovery and academic customers with overlapping value propositions.

Others

• NanoTemper Technologies: Acquirer of Envue and broader biophysical analysis incumbent offering DSF (Prometheus), MST, and now Dianthus α/NSM. Comparable because it sells to the same drug-discovery customers and increasingly bundles NSM into its portfolio.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/envue-technologies

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Envue Technologies